Trials / Conditions / Refractory Myelodysplastic/Myeloproliferative Neoplasm
Refractory Myelodysplastic/Myeloproliferative Neoplasm
4 registered clinical trials studyying Refractory Myelodysplastic/Myeloproliferative Neoplasm — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Ne NCT06523556 | Uma Borate | Phase 1 / Phase 2 |
| Recruiting | Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic S NCT05549661 | Mayo Clinic | Phase 1 |
| Terminated | Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial NCT03878524 | OHSU Knight Cancer Institute | Phase 1 |
| Recruiting | Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute My NCT04140487 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |